A carregar...

Low-dose 2-deoxy glucose stabilises tolerogenic dendritic cells and generates potent in vivo immunosuppressive effects

Cell therapies for autoimmune diseases using tolerogenic dendritic cells (tolDC) have been promisingly explored. A major stumbling block has been generating stable tolDC, with low risk of converting to mature immunogenic DC (mDC), exacerbating disease. mDC induction involves a metabolic shift to lac...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Mol Life Sci
Main Authors: Christofi, M., Le Sommer, S., Mölzer, C., Klaska, I. P., Kuffova, L., Forrester, J. V.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8004500/
https://ncbi.nlm.nih.gov/pubmed/33074350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00018-020-03672-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!